The mean concentration of methylated p16 and p15 was significantly higher in HNSCC patients compared to healthy controls (p = 0.016 and 0.0037 respectively), but no cut-off values for background methylation was defined. Here, CDKN2A is linked to head and neck squamous cell carcinoma.